Assembly Biosciences's market cap is currently $81.04M. The company's EPS TTM is $-7.144; its P/E ratio is ―; Assembly Biosciences is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-1.79. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.16M	$ 0.00	$ 6.25M	$ 79.11M	$ 15.96M
Gross Profit	$ -41.74M	$ -498.00K	$ 5.79M	$ 79.00M	$ 15.88M
Operating Income	$ -64.65M	$ -94.11M	$ -132.69M	$ -64.78M	$ -102.71M
EBITDA	$ -64.20M	$ -92.59M	$ -91.93M	$ -64.78M	$ -102.71M
Net Income	$ -61.23M	$ -92.07M	$ -129.85M	$ -59.53M	$ -97.63M
Balance Sheet
Cash & Short-Term Investments	$ 130.25M	$ 91.61M	$ 146.63M	$ 216.41M	$ 274.04M
Total Assets	$ 136.82M	$ 101.79M	$ 191.06M	$ 283.25M	$ 339.91M
Total Debt	$ 2.34M	$ 3.46M	$ 6.48M	$ 10.13M	$ 12.27M
Net Debt	$ -17.50M	$ -48.95M	$ -39.15M	$ -49.31M	$ -34.46M
Total Liabilities	$ 95.73M	$ 19.13M	$ 22.13M	$ 42.68M	$ 66.69M
Stockholders' Equity	$ 41.10M	$ 82.66M	$ 168.93M	$ 240.58M	$ 273.22M
Cash Flow
Free Cash Flow	$ 22.49M	$ -84.56M	$ -96.49M	$ -65.18M	$ -85.62M
Operating Cash Flow	$ 22.74M	$ -84.46M	$ -93.40M	$ -62.96M	$ -84.07M
Investing Cash Flow	$ -69.14M	$ 90.64M	$ 26.52M	$ 68.07M	$ -50.32M
Financing Cash Flow	$ 13.82M	$ 614.00K	$ 53.06M	$ 7.60M	$ 139.65M

Currency in USD

Assembly Biosciences Earnings and Revenue History

Income Statement >

Assembly Biosciences Debt to Assets

Balance Sheet >

Assembly Biosciences Cash Flow

Cash Flow >

Assembly Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing